![\"Video](\"https:\/\/www.dumonceau-urologie.fr\/wp-content\/uploads\/2026\/04\/cancer-de-la-prostate-quels-sont-les-signes-a-surveiller-vtb-69e238291cf2a.jpg\")
<\/p>\n<\/p>\n
The question comes up very often among men over 50<\/a> : are there any warning signs of prostate cancer<\/strong> ? Should one worry at the slightest urinary problem?<\/p>\n The answer, very clearly, is this: in the vast majority of cases, no<\/strong> .<\/p>\n This is an essential point to understand, because it avoids a lot of unnecessary anxiety and above all allows us to focus on what really matters: regular screening<\/a><\/strong> .<\/p>\n When a man starts urinating more frequently, with more difficulty, or experiences more urgent urges, he often immediately thinks of cancer. In practice, these symptoms are most often linked to benign prostatic hyperplasia<\/a> (BPH)<\/strong> , also known as benign prostatic hypertrophy.<\/p>\n The most common signs are well known:<\/p>\n These symptoms are typical of benign prostatic hyperplasia (BPH<\/strong> ). They are not<\/strong> , as a rule, signs of prostate cancer.<\/p>\n In other words, a man who experiences urinary difficulties should not immediately conclude that he has cancer. That would be a very common mistake.<\/p>\n The problem with prostate cancer<\/strong> is precisely that it is often silent in its early stages. Localized, early-stage cancer usually does not cause any specific symptoms<\/strong> .<\/p>\n If clinical signs do appear due to the cancer itself, this most often corresponds to very advanced<\/strong> forms, sometimes even metastatic<\/strong> .<\/p>\n This is a crucial point: the absence of symptoms does not mean the absence of cancer<\/strong> , and conversely, the presence of urinary problems does not mean that there is cancer.<\/p>\n Today, with regular medical monitoring, prostate cancer should no longer be discovered at such an advanced stage that it already causes significant urinary difficulties.<\/p>\n Just a few decades ago, late diagnoses were much more common. Dramatic situations could arise, with cancers only being revealed by major complications.<\/p>\n A striking example is that of bone metastases in the spine. In very advanced stages, prostate cancer can lead to vertebral compression fractures and, in extreme cases, paraplegia.<\/p>\n Today, this type of discovery should practically never occur during routine monitoring. And that's excellent news. It shows how much early detection<\/strong> has changed patient care.<\/p>\n Prostate cancer screening does not prevent cancer from developing. This needs to be clear. Screening does not prevent the onset of cancer<\/strong> .<\/p>\n On the other hand, it allows something fundamental: detecting a possible cancer in its early stages<\/strong> , before it becomes advanced, symptomatic or metastatic.<\/p>\n This is the whole logic behind annual monitoring for men from the age of 50. When cancer is regularly monitored, it has a much greater chance of being discovered at an early stage, when it is not yet showing any signs.<\/p>\n This monitoring is traditionally based on:<\/p>\n PSA testing<\/a><\/strong> is one of the key screening tools. Its value lies precisely in detecting abnormalities even when no symptoms are present.<\/p>\n A high PSA level does not automatically mean that cancer is present, but it can raise awareness and lead to further investigations. It is therefore a useful warning sign within the framework of structured monitoring.<\/p>\n The idea is not to be alarmed by a single value, but to interpret it within a context: age, clinical examination, evolution over time, prostatic context.<\/p>\n The message is simple: from the age of 50<\/strong> , it is reasonable to talk about prostate cancer screening with your doctor and to consider annual follow-up<\/strong> .<\/p>\n This regularity is important. A check-up done once and then forgotten for several years loses much of its value. What protects against late-stage disease is not a single examination, but the continuity of follow-up.<\/p>\n Rather than worrying about common urinary symptoms, remember this:<\/p>\n In practice, the right approach is neither panic nor denial. It is simple, regular, and age-appropriate medical monitoring.<\/p>\n If you are over 50 and have urinary problems, the most likely diagnosis is not prostate cancer, but a benign prostatic hyperplasia (BPH).<\/p>\n Even if you have no symptoms, that doesn't mean you shouldn't get tested. That's precisely the point of screening: to detect early what hasn't yet manifested itself<\/strong> .<\/p>\n The right approach, therefore, is not to look for early warning signs at all costs. The right approach is to implement annual screening<\/strong> with a digital rectal exam<\/a> and PSA test, in order to detect any potential cancer at an early stage, when it is still silent.<\/p>\n When it comes to the prostate, waiting for symptoms is not a strategy. Prevention is.<\/strong><\/p>\n<\/p>\n Urinary problems are almost never a sign of prostate cancer<\/h2>\n
\n
When symptoms appear, they are often in advanced stages.<\/h2>\n
Why severe cases have become much rarer<\/h2>\n
The real challenge: early detection, before symptoms appear<\/h2>\n
\n
What is the purpose of the PSA?<\/h2>\n
At what age should screening be considered?<\/h2>\n
When should we really be worried?<\/h2>\n
\n
The key takeaway<\/h2>\n